Zyla Life Sciences Liabilities Subject to Compromise
Zyla Life Sciences had Liabilities Subject to Compromise of $138.88 million as of 2019-01-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Reorganizations
us-gaap:LiabilitiesSubjectToCompromise · last filed 2020-05-14
- 2019-01-31: Liabilities Subject to Compromise $138.88M.
- 2018-12-31: Liabilities Subject to Compromise $139.59M.
| Period end | Liabilities Subject to Compromise |
|---|---|
| 2019-01-31 | $138.88M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $139.59M 10-K · filed 2020-03-26 |